Steven Rockman

Summary

Affiliation: Research and Development
Country: Australia

Publications

  1. pmc Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine
    Steven Rockman
    CSL Limited, Parkville, Victoria, Australia
    J Virol 87:3053-61. 2013
  2. pmc An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection
    Laura J White
    Global Vaccines Inc, Research Triangle Park, NC, USA
    J Virol 87:3409-24. 2013
  3. doi request reprint Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies
    Steve Rockman
    CSL Limited Poplar Road, Parkville, 3052 Victoria, Australia Electronic address
    Mol Immunol 53:435-42. 2013
  4. doi request reprint Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines
    Steven Rockman
    CSL Limited, Parkville, 3052 Victoria, Australia
    Vaccine 30:3618-23. 2012
  5. doi request reprint The use of hyperimmune serum for severe influenza infections*
    Steven Rockman
    CSL Limited, Parkville, Victoria, Australia
    Crit Care Med 40:973-5. 2012
  6. doi request reprint Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA
    Erin E Verity
    CSL Ltd, Parkville, Vic, Australia
    Influenza Other Respi Viruses 6:101-9. 2012
  7. doi request reprint Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion
    Jesse Bodle
    CSL Ltd, Parkville, Vic, Australia
    Influenza Other Respi Viruses 7:191-200. 2013
  8. pmc Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization
    Deborah Middleton
    Australian Animal Health Laboratory, Geelong, Victoria, Australia
    J Virol 83:7770-8. 2009
  9. doi request reprint A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody
    David Pejoski
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia
    Immunol Cell Biol 88:605-11. 2010
  10. ncbi request reprint Pre-pandemic and pandemic influenza vaccines
    Steven Rockman
    CSL Ltd, Parkville, Victoria, Australia
    Hum Vaccin 6:792-801. 2010

Collaborators

  • Lorena Brown
  • Laura J White
  • Aravinda de Silva
  • Mark A Baker
  • Erin E Verity
  • Deborah Middleton
  • Jesse Bodle
  • Chi Ong
  • Robert Shaw
  • Ian Barr
  • David Pejoski
  • Kirsten Vandenberg
  • Ian G Barr
  • Sarina Camuglia
  • Catherine T Agius
  • David C Jackson
  • Weiguang Zeng
  • Martin Pearse
  • Jessica Klippel
  • David Ryan
  • Sue Lowther

Detail Information

Publications10

  1. pmc Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine
    Steven Rockman
    CSL Limited, Parkville, Victoria, Australia
    J Virol 87:3053-61. 2013
    ..The data also highlight that an inducer of cross-protective immunity is the NA, a protein whose levels are not normally monitored in vaccines and whose capacity to induce immunity in recipients is not normally assessed...
  2. pmc An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection
    Laura J White
    Global Vaccines Inc, Research Triangle Park, NC, USA
    J Virol 87:3409-24. 2013
    ..Balanced responses and protection in macaques provided further support for exploring the immunogenicity and safety of this vaccine candidate in humans...
  3. doi request reprint Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies
    Steve Rockman
    CSL Limited Poplar Road, Parkville, 3052 Victoria, Australia Electronic address
    Mol Immunol 53:435-42. 2013
    ....
  4. doi request reprint Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines
    Steven Rockman
    CSL Limited, Parkville, 3052 Victoria, Australia
    Vaccine 30:3618-23. 2012
    ..These results implicate non-classical protective mechanisms that prevent severe pulmonary disease but not viral shedding and imply that particular non-adjuvanted vaccines may have retained the ability to induce these responses...
  5. doi request reprint The use of hyperimmune serum for severe influenza infections*
    Steven Rockman
    CSL Limited, Parkville, Victoria, Australia
    Crit Care Med 40:973-5. 2012
    ..Reports of the use of hyperimmune serum in human influenza infection are sporadic and studies in animal models are limited...
  6. doi request reprint Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA
    Erin E Verity
    CSL Ltd, Parkville, Vic, Australia
    Influenza Other Respi Viruses 6:101-9. 2012
    ..The emergence of H5N1 and pandemic spread of novel H1N1/2009 viruses reinforces the need to have strategies in place to rapidly develop seed viruses for vaccine manufacture...
  7. doi request reprint Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion
    Jesse Bodle
    CSL Ltd, Parkville, Vic, Australia
    Influenza Other Respi Viruses 7:191-200. 2013
    ..The 2009 influenza pandemic highlighted the need to develop alternate assays that are able to rapidly quantitate HA antigen for vaccine formulation...
  8. pmc Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization
    Deborah Middleton
    Australian Animal Health Laboratory, Geelong, Victoria, Australia
    J Virol 83:7770-8. 2009
    ....
  9. doi request reprint A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody
    David Pejoski
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia
    Immunol Cell Biol 88:605-11. 2010
    ..Abs to the truncated M2e sequence were also able to significantly reduce the viral load in airways of BALB/c mice after challenge with live influenza virus...
  10. ncbi request reprint Pre-pandemic and pandemic influenza vaccines
    Steven Rockman
    CSL Ltd, Parkville, Victoria, Australia
    Hum Vaccin 6:792-801. 2010
    ..This review explores developing pandemic and pre-pandemic vaccines in the context of highly virulent avian H5N1 virus and the influenza H1N1 pandemic of 2009...